InvestorsHub Logo
Followers 60
Posts 9579
Boards Moderated 0
Alias Born 12/30/2005

Re: Investor2014 post# 442491

Wednesday, 12/13/2023 7:25:13 PM

Wednesday, December 13, 2023 7:25:13 PM

Post# of 473338

Too much emotion and too little experienced cool calm review of fact is not a good strategy in biotech investing.



Talking can be agreeable or disagreeable. Being agreeable/disagreeable invokes emotion. AVXL listed the accepted/unaccepted facts. Cool calm reviews are relative in/on adversarial/amiable terms. It gets clear when asking if this will ever be an $8 stock again. Everything else gets filtered and framed by adversarial and oft repeated rhetoric.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News